Maria E. Bedoya Toro - 17 Feb 2026 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Reporting relationship
SVP, Regulatory Affairs
Issuer ticker
DRMA
Reported as of
17 Feb 2026
Net transaction value
+$1,270
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Mar 2026, 17:44:21 UTC
Prior SEC filing
06 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gerald T. Proehl, Attorney-in-Fact

Key filing fact

Maria E. Bedoya Toro filed Form 4 for Dermata Therapeutics, Inc. (DRMA) on 17 Mar 2026.

Key facts

  • This page summarizes Maria E. Bedoya Toro's Form 4 filing for Dermata Therapeutics, Inc. (DRMA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Mar 2026, 17:44.

Change

  • Previous filing in this sequence was filed on 06 Jan 2026.
  • Current net transaction value: +$1,270.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001400048 Primary reporting owner

Bedoya-Toro Munera Maria E

Relationship
SVP, Regulatory Affairs
Address
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
Signature date
17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DRMA transaction

Common Stock

Purchase

Transaction value
$1,270
Shares
+1,000
Change %
+8333%
Price
$1.27
Shares after
1,012
Date
17 Feb 2026
Ownership
Direct
DRMA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
34
Date
17 Feb 2026
Ownership
Munera Family Trust
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .